Abstract:CDH1, a cell adhesion molecule, which plays a key role in maintaining the epithelial phenotype, is regarded as an invasion-suppressor gene in light of accumulating evidence from in vitro experiments and clinical observations. In an attempt to clarify the mechanism responsible for inactivation of this gene in carcinomas, we investigated the methylation status of the CDH1 gene 5'-CpG islands and its regulatory mechanism in the progression of esophageal squamous cell carcinoma. Real-time methylation-specific polymerase chain reaction (qMSP) and treatment with the demethylating agent 5-aza-2'-deoxycytidine (5-Aza-CdR) were conducted to analyze the methylation status at the CDH1 promoter region in the human esophageal carcinoma cell lines, EC1 and EC9706. A total of 235 invasive esophageal squamous cell carcinomas (ESCC) at stages I-IV and their corresponding normal tissue samples, were included in an immunohistochemistry study and methylation analysis of CDH1. The results demonstrate that in EC1 and EC9706 cells, the CDH1 promoter is methylated and treatment with 5-Aza-CdR restored CDH1 expression. Enhanced CDH1 expression decreased cell migration, invasion ability and increased adhesion ability. Decreased CDH1 expression was detected in 59.6% of ESCC tissues, compared with their adjacent non-neoplastic epithelia, which had a close correlation with the primary tumor status, lymph node status, distant metatasis and clinicopathologic stage. Hypermethylation at the CDH1 promoter was detected in 97.9% of 140 cases of ESCC with low CDH1 expression. The methylation of CDH1 promoters (P=0.929) was closely correlated with the lack of expression of their corresponding proteins. The Cox regression model for survival analysis showed that increases in CDH1 methylation had a greater impact on the prognosis than tumor clinical stage. These findings suggest that CDH1 gene silencing by promoter hypermethylation and the resultant reduction of CDH1 expression may play an important role in the progression of ESCC. CDH1 methylation was a significant predictor of survival in ESCC patients after surgery.

Correlation of the Methylation Status of CDH1 Gene Promoter and the Metastasis of Human Epithelial Ovarian Carcinomas

Association between CDH1 promoter methylation and E-cadherin protein expression and its clinical significance in primary epithelial ovarian carcinomas

Effects of CDH1 gene mutation/methylation on expression of E-cadherin in the epithelial ovarian carcinomas

Deletion of OPCML Gene and Promoter Methylation in Ovarian Epithelial Carcinoma

The association between CDH1 promoter methylation and patients with ovarian cancer: a systematic meta-analysis

Expression and Promoter Methylation Status of Mismatch Repair Gene Hmlh1 and Hmsh2 in Epithelial Ovarian Cancer.

Methylation of RUNX3 Gene in Epithelial Ovarian Carcinoma

Hypermethylation-modulated Down-Regulation of CDH1 Expression Contributes to the Progression of Esophageal Cancer.

Clinical Significance of Methylation of E-cadherin and P14arf Gene Promoters in Skin Squamous Cell Carcinoma Tissues.

The clinicopathological significance of HES1 promoter hypomethylation in patients with colorectal cancer.

A Relationship Between the Methylation of Epithelial Cadherin Gene and Biological Behaviour of Lung Cancer

Brca1 Promoter Hypermethylation in Sporadic Epithelial Ovarian Carcinoma: Association with Low Expression of Brca1, Improved Survival and Co-Expression of Dna Methyltransferases

OPCML Gene Promoter Methylation and Gene Expression in Tumor and Stroma Cells of Invasive Cervical Carcinoma

[Model of Aberrant DNA Methylation Patterns and Its Applications in Epithelial Ovarian Cancer.].

Hypermethylation of Hmlh1 and Microsatellite Instability in Ovarian Mucinous Tumors

Down-regulation of CXCL12 Mrna Expression by Promoter Hypermethylation and Its Association with Metastatic Progression in Human Breast Carcinomas.

Clinical outcomes of downregulation of E-cadherin gene expression in non-small cell lung cancer.

Aberrant Promoter Methylation of T-cadherin in Sera is Associated with a Poor Prognosis in Oral Squamous Cell Carcinoma

Relationship and Significance of Expression of E-cadherin Proteins and Methylation of Promoter in Colorectal Cancer Tissues

Association between YYl Methylation of E-cadherin in Breast Cancer

Promoter Methylation Changes in DNA Damage-Response Genes in Ovarian Cancer and Their Correlation with Prognosis